Helicobacter Pylori

Personalized vs Standard of Care Treatment for Helicobacter Pylori Eradication Among Veterans

Helicobacter Pylori Infection Status and Pathological Features for Predicting Gastric Cancer Biological Behavior and Prognosis: A Real-World Observational Study

Vonoprazan-Based Triple Therapy in Comparison With Extended Sequential Therapy

Study of the Esophageal String Test (EST) for the Diagnosis of Helicobacter Pylori

Keverprazan Combined With Amoxicillin for the Treatment of Helicobacter Pylori

Vonoprazan-based Versus Esomeprazole-based Triple Therapy for Helicobacter Pylori Eradication

7-Day Vonoprazan, High-Dose Amoxicillin, and Bismuth Therapy

Prevalence of Helicobacter Pylori Infection and Gastric Cancer in the West Indies

H. Pylori Eradication With Argon Plasma During Endoscopy

Prospective Gastric Cancer Screening Using Helicobacter Pylori High-Risk Single Nucleotide Polymorphism Detection

Distribution Characteristics of Helicobacter Pylori

Efficacy and Safety of Keverprazan-amoxicillin Dual Therapy for Helicobacter Pylori First-line Treatment

Effect of Oral Helicobacter Pylori Infection on the Efficacy of Gastroluminal Helicobacter Pylori Eradication Therapy

Differences in Gastric Microbiota in Patients Who Were Infected Between CagA Positive and Negative Helicobacter Pylori

14-day Susceptibility-guided Bismuth Quadruple Therapy for Multiple Drug Resistant H. Pylori Infection

Susceptibility-guided Bismuth Quadruple Therapy for Multiple-resistant Helicobacter Pylori Strains

Helicobacter Pylori, Atrophic Gastritis and Intestinal Metaplasia Registry and Prospective Study

Helicobacter Pylori and Vonoprazan Dual Therapy

Study Comparing Sequential and Concomitant Therapy for Helicobacter Pylori Eradication in Routine Clinical Practice

A Study to Evaluate the Efficacy and Safety of Bismuth-Containing Quadruple Therapy With Oral Vonoprazan (TAK-438) 20 mg Compared to Esomeprazole 20 mg Twice Daily in Paticipants With Helicobacter Pylori Infection